Abstract
Unnecessary laboratory tests present health risks and increase healthcare costs. We propose a new deep learning model to identify unnecessary hemoglobin (Hgb) tests for patients admitted to the hospital. Machine learning models might generate less reliable results due to noisy inputs containing low-quality information. We estimate prediction confidence to measure reliability of predicted results. Using a “select and predict” design philosophy, we aim to maximize prediction performance by selectively considering samples with high prediction confidence for recommendations. We use a conservative definition of unnecessary laboratory tests, which we define as stable and below the lower normal bound (LBNR). Our model accommodates irregularly sampled observational data to make full use of variable correlations (i.e., with other laboratory test values) and temporal dependencies (i.e., previous observations) in order to select candidates for training and prediction. Using data collected from a teaching hospital in Houston, our model achieves Hgb prediction performance with a normality AUC at 95.89% and a Hgb stability AUC at 95.94%, while recommending a reduction of 9.91% of Hgb tests that were deemed unnecessary.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
XJ is CPRIT Scholar in Cancer Research (RR180012), and he was supported in part by Christopher Sarofim Family Professorship, UT Stars award, UTHealth startup, the National Institute of Health (NIH) under award number R01AG066749 and U01TR002062. LL is supported by a KL2 Mentored Career Development Award through the University of Texas Health Science Center at Houston. EVB is supported in part by National Center for Advancing Translational Sciences (NCATS) UL1TR000371 the Cancer Prevention and Research Institute of Texas (CPRIT), under award RP170668 and the Reynolds and Reynolds Professorship in Clinical Informatics.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our research study was approved by the Committee for the Protection of Human Subjects (the UTHSC-H IRB) using the protocol HSC-MS-21-0452. There was a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
These clinical data contain potentially identifying and sensitive patient information, which cannot be made available due to the privacy protection policy of the hospital.
